Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $20,250 | 6 | 95.0% |
| Travel and Lodging | $778.14 | 2 | 3.7% |
| Food and Beverage | $250.37 | 3 | 1.2% |
| Education | $32.27 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Celgene Corporation | $14,042 | 7 | $0 (2020) |
| Merck Sharp & Dohme Corporation | $4,500 | 1 | $0 (2018) |
| Novo Nordisk Inc | $2,752 | 3 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $16.86 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $2,720 | 2 | Novo Nordisk Inc ($2,720) |
| 2020 | $3,032 | 2 | Celgene Corporation ($3,000) |
| 2019 | $8,963 | 5 | Celgene Corporation ($8,946) |
| 2018 | $6,596 | 3 | Merck Sharp & Dohme Corporation ($4,500) |
All Payment Transactions
12 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/16/2021 | Novo Nordisk Inc | — | Consulting Fee | Cash or cash equivalent | $1,360.00 | General |
| 04/15/2021 | Novo Nordisk Inc | — | Consulting Fee | Cash or cash equivalent | $1,360.00 | General |
| 08/21/2020 | Celgene Corporation | REBLOZYL (Biological) | Consulting Fee | Cash or cash equivalent | $3,000.00 | General |
| Category: Hematology | ||||||
| 07/15/2020 | Novo Nordisk Inc | — | Education | In-kind items and services | $32.27 | General |
| 04/03/2019 | Celgene Corporation | Luspatercept (Drug) | Consulting Fee | Cash or cash equivalent | $8,050.00 | General |
| 03/22/2019 | Celgene Corporation | Luspatercept (Drug) | Travel and Lodging | In-kind items and services | $641.29 | General |
| 03/22/2019 | Celgene Corporation | Luspatercept (Drug) | Travel and Lodging | In-kind items and services | $136.85 | General |
| 03/22/2019 | Celgene Corporation | Luspatercept (Drug) | Food and Beverage | In-kind items and services | $117.74 | General |
| 03/01/2019 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $16.86 | General |
| 12/20/2018 | Celgene Corporation | Luspatercept (Drug) | Consulting Fee | Cash or cash equivalent | $1,980.00 | General |
| 12/01/2018 | Celgene Corporation | Luspatercept (Drug) | Food and Beverage | In-kind items and services | $115.77 | General |
| 09/06/2018 | Merck Sharp & Dohme Corporation | V114 (Biological) | Consulting Fee | Cash or cash equivalent | $4,500.00 | General |
| Category: VACCINE | ||||||
About Dr. Charles Quinn, MD
Dr. Charles Quinn, MD is a Pediatric Hematology-Oncology healthcare provider based in Cincinnati, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1962465864.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Charles Quinn, MD has received a total of $21,311 in payments from pharmaceutical and medical device companies, with $2,720 received in 2021. These payments were reported across 12 transactions from 4 companies. The most common payment nature is "Consulting Fee" ($20,250).
Practice Information
- Specialty Pediatric Hematology-Oncology
- Location Cincinnati, OH
- Active Since 04/11/2006
- Last Updated 06/02/2010
- Taxonomy Code 2080P0207X
- Entity Type Individual
- NPI Number 1962465864
Products in Payments
- Luspatercept (Drug) $11,042
- V114 (Biological) $4,500
- REBLOZYL (Biological) $3,000
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatric Hematology-Oncology Doctors in Cincinnati
Sonata Jodele, M.d, M.D
Pediatric Hematology-Oncology — Payments: $123,982
Eric Mullins, Md, MD
Pediatric Hematology-Oncology — Payments: $106,538
Russell Ware, Md, MD
Pediatric Hematology-Oncology — Payments: $72,502
Michael Jordan, Md, MD
Pediatric Hematology-Oncology — Payments: $68,335
Dr. Pooja Khandelwal, M.d, M.D
Pediatric Hematology-Oncology — Payments: $43,794
Dr. Cristina Tarango, M.d, M.D
Pediatric Hematology-Oncology — Payments: $40,708